Search For "pharma revenue"
Generic Semaglutide patent expiry opens over Rs 50,000 Crore opportunity f
Updated : 4 months, 3 weeks ago IST
In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth by 0.5-1%. Prices are anticipated to be 30-50% lower than current levels initially, with the potential for deeper cuts of up to 70-75% o
Read More
Samsung Biologics secures half of Japan's top 10 pharmas as clients
Updated : 7 months, 2 weeks ago IST
Samsung Biologics Co is accelerating its expansion in Japan, the world's third-largest pharmaceutical market. The South Korean company has signed contracts with half of Japan's top 10 pharmaceutical and biotech companies, rapidly strengthening its presence in the region, according to a repor
Read More
Vaishali Pharma's H1 FY24 Revenue Up By 9%
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], November 9: Vaishali Pharma Limited (NSE - VAISHALI), engaged in production and marketing of a diverse range of pharmaceutical products, announced its unaudited Financial Results for H1 & Q2 FY24.
Read More
JB Pharma records revenue growth of 32 per cent to Rs 793 crores in Q3 FY2
Updated : 3 years, 3 months ago IST
Mumbai (Maharashtra) [India], February 11 (ANI/PNN): JB Pharma, one of the fastest-growing pharmaceutical companies in India, announced record revenue growth of 32 per cent to Rs 793 crore in Q3 FY23.
Read More
Sun Pharma shares dip after disappointing Q4 results
Updated : 3 years, 12 months ago IST
Mumbai (Maharashtra) [India], May 31 (ANI): Share price of Sun Pharmaceutical Industries slumped by around four per cent on Tuesday, a day after the company announced Rs 2,277.2 crore net loss for the quarter ended March 2022.
Read More
Sun Pharma posts Rs 2,227 crore net loss in Q4 of 2021-22
Updated : 3 years, 12 months ago IST
Mumbai (Maharashtra) [India], May 30 (ANI): Sun Pharmaceuticals Industries on Monday reported a consolidated net loss of Rs 2,227.38 crore for the quarter ended March 2022 as against a net profit of Rs 848 crore recorded in the corresponding period of the previous year, hit by one-time charg
Read More